Invesco Ltd. grew its position in CBIZ, Inc. (NYSE:CBZ - Free Report) by 157.2% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 769,209 shares of the business services provider's stock after acquiring an additional 470,095 shares during the period. Invesco Ltd. owned about 1.53% of CBIZ worth $62,944,000 at the end of the most recent quarter.
Several other hedge funds have also modified their holdings of the company. Bank of Montreal Can acquired a new stake in CBIZ in the fourth quarter valued at approximately $240,000. Russell Investments Group Ltd. lifted its stake in CBIZ by 133.0% in the 4th quarter. Russell Investments Group Ltd. now owns 36,225 shares of the business services provider's stock valued at $2,964,000 after buying an additional 20,678 shares in the last quarter. Envestnet Asset Management Inc. boosted its holdings in CBIZ by 5.9% in the 4th quarter. Envestnet Asset Management Inc. now owns 74,964 shares of the business services provider's stock worth $6,134,000 after buying an additional 4,145 shares during the last quarter. Wells Fargo & Company MN increased its stake in CBIZ by 23.0% during the 4th quarter. Wells Fargo & Company MN now owns 42,803 shares of the business services provider's stock worth $3,503,000 after buying an additional 8,014 shares in the last quarter. Finally, Landscape Capital Management L.L.C. acquired a new position in shares of CBIZ during the fourth quarter valued at approximately $279,000. 87.44% of the stock is owned by hedge funds and other institutional investors.
Insider Activity at CBIZ
In other news, Director Benaree Pratt Wiley sold 6,526 shares of the company's stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $71.75, for a total value of $468,240.50. Following the transaction, the director now directly owns 41,759 shares in the company, valued at approximately $2,996,208.25. This represents a 13.52 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 5.40% of the stock is currently owned by insiders.
CBIZ Trading Down 1.6 %
NYSE CBZ traded down $1.24 on Friday, reaching $77.45. 456,438 shares of the company were exchanged, compared to its average volume of 330,920. CBIZ, Inc. has a fifty-two week low of $62.66 and a fifty-two week high of $90.13. The stock has a market capitalization of $4.19 billion, a P/E ratio of 32.82 and a beta of 0.90. The business's fifty day moving average price is $76.71 and its 200 day moving average price is $77.62. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 0.36.
Analyst Ratings Changes
Several brokerages recently commented on CBZ. William Blair reiterated an "outperform" rating on shares of CBIZ in a research report on Thursday, February 27th. StockNews.com downgraded shares of CBIZ from a "hold" rating to a "sell" rating in a research note on Tuesday, February 25th.
Check Out Our Latest Stock Report on CBIZ
About CBIZ
(
Free Report)
CBIZ, Inc provides financial, insurance, and advisory services in the United States and Canada. It operates through Financial Services, Benefits and Insurance Services, and National Practices segments. The Financial Services segment offers accounting and tax, financial advisory, valuation, risk and advisory, and government healthcare consulting services.
Featured Articles

Before you consider CBIZ, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CBIZ wasn't on the list.
While CBIZ currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.